The first exhibition of Hangzhou Bo's resumption of work in July is ready to go: 200+ heavyweight speakers, more than 5,000 people in the biopharmaceutical circle have pre-registered!

The 9th International Biopharmaceutical Conference and Exhibition of BioCon Expo will start from July 20-22 at Hangzhou International Expo Cent.

Based on the brand effect of BioCon for many years, BioCon Expo has won the attention and support of many industry experts and well-known enterprises/units as soon as it was made publ.

The total exhibition area of ​​this exhibition exceeds 10,000 square meters, and more than 250 leading suppliers are expected to participa.

The stars shine, 200+ heavy starters

▪ Led by academicians and authoritative PIs

Rao Zihe, Academician of the Chinese Academy of Sciences, Molecular Biophysics and Structural BiologistDeng Zixin, Academician of the Chinese Academy of Sciences, Microbial Molecular GeneticistChen Zhinan, Academician of the Chinese Academy of Engineering, Cell Biology and Biotechnology Drug ExpertTan Weihong, Academician of the Chinese Academy of Sciences, Foundation of the Chinese Academy of Sciences Song Erwei, Director of the Institute of Medicine and Oncology (Institute of Medicine, Chinese Academy of Sciences), Professor of Hunan University , Lu Hongzhou,Academician of the Chinese Academy of Sciences, President of Sun Yat-sen Memorial Hospital of Sun Yat-Sen University, Deputy Secretary of the Party Committee and President of Shenzhen Third People's Hospital, and Academician of the American Academy of MicrobiologyPan Hongming, Zhou Caicun , Chief Physician, Professor and Doctoral Supervisor of Run Run Run Shaw Hospital Affiliated to Zhejiang University, Director of the Technical Guidance Center for Tumor Targeted Therapy of Zhejiang Provincial Health and Health Commission,Director of the Oncology Department of Shanghai Pulmonary Hospital Affiliated to Tongji University, Director of the Cancer Institute of the Medical Colle.

▪ Nucleic acid drug/vaccine product field

InBev, CEOof ExproBio Lu Yang, Chairman and Chief Scientist of Sirnaomics Suzhou Sino Biomedical Technology .

▪ Field of cellular immunotherapy products

Huang Hai, Qian Cheng, CEO of FosunKite, Chief Scientist of Chongqing Precision Bio, part-time Director ofBiotherapy Wenzheng, Vice Dean/Professor of School of Life Sciences, East China Normal UniversityLiu Yanwei, Vice President of Takeda Pharmaceutical Li Yiping, Head of Registration Department in China , Yang Lin,Co-Founder, Chairman and CEO of WuXi Junuo (Confirmed) , Liu Bizuo,Founder and Chairman of Boshengji Medical Technology (Suzhou), President of Sibiman Biotechnology Li Bin, Distinguished Professor of Shanghai Jiaotong University, Deputy Director of Scientific Research & Research Group Leader of Shanghai Institute of Immunology Liu Hong, Chairman and General Manager of Guojian Chengnuo Li Jianqiang, Chairman of Senlang Biotechnology Zhang Yu, Chief Scientific Officer of Zhongyuan Xiehe Song Xiaodong , David He, CEO of Utijisheng Bio, Chen Jie, Chief Technology Officer and Executive Vice President of Reindeer Medical , Zhang Ke, Chief Medical Officer of Beiheng Bio, Liu Yarong, Chief Scientific Officer of Xinghand Bio, Tao Tongjing, CEO of Sand Biotechnology .

▪ Field of gene therapy products

Li Bin, Chairman & Founder of Neophos BiotechChen Xiongwen, Chairman of Beijing Novogene, Dean of Tianjin Medical University School of PharmacyWang Bing, Associate Professor of University of Pittsburgh School of MedicineWu Zhenhua, Hangzhou Jiayin Biotechnology .

▪ Antibody protein drug field

Chen Gang, Chief Expert of Shanghai Institute of Food and Drug Inspection, Director of Key Laboratory of Therapeutic Monoclonal Antibody Quality Control of Shanghai Institute of Food and Drug InspectionZhang Lianshan, Deputy General Manager of Jiangsu Hengrui Pharmaceutical .

▪ Other hot biological product fields (new vaccines/oncolytic viruses/cytokine drugs/peptide drugs…)

Jiang Shibo, Director of the Institute of Pathogenic Microbiology, Fudan University, Academician of the American Academy of Microbiology (AAM) (Fellow)Zhang Yuntao, Vice President and Chief Scientist of China BiotechnologyZhu Tao, Co-founder and CSO ofCanSino Kong Jian, CEOof Beijing Green Bamboo Biotechnology .

▪ BD and investment and financing fields

Mingde Xia, Founder, Chairman and CEO of Innolake Pharmaceuticals Ni Binhui,Chief Investment Officer and Commercial Officer of Qilu Pharmaceutical GroupWang Chong, Chief Business Officer of Zai Lab,Mao Hua, Partner and Partner of Frost & Sullivan Greater China Zheng Yufen, managing director , Liu Dan,founder and chairman of Yueyin Medical Fund, Dong Zengjun,senior partner of CDH Investments , Jin Qi,co-founder of Jianheng Technology, Wang Peijun, co-founderof Shanghai Jingqi Biology, and managing partner of Kaitai Capital,Zhao Weiwen, Partner of Oriental Fortune Healthcare , Dai Han, Executive President of Blue Rainbow Life Science Accelerator and Managing Partner of Miracle Light Venture Fund, Li Jing,Chief Innovation Officer and Investment Director of Via Group , Founder of Science Bridge, Angel Investor Ge Yongbin, Senior Partner of Zhong Lun Law Fir.

15+ segmented forums and opening ceremony in the same period

Full firepower, more authoritative events

Thanks to the years of industry accumulation of the BioCon brand, the "BioCon Awards" will recognize and share the cutting-edge, progressive, innovative and top biotechnology forces in the biotechnology industry at home and abroad in the past year, aiming to become the most influential player in the biotechnology and pharmaceutical indust.

BioCon Awards debut authoritative review expert lineup

❖Rao Zihe, academician of Chinese Academy of Sciences, molecular biophysicist and structural biologist ❖DengZixin, academician of Chinese Academy of Sciences, microbial molecular geneticist , Director of Institute of Basic Medicine and Oncology, Chinese Academy of Sciences (Institute of Medicine, Chinese Academy of Sciences), Professor of Hunan University ❖ Song Erwei, Academician of Chinese Academy of Sciences, President of Sun Yat-sen Memorial Hospital of Sun Yat-Sen University Academician of American Academy of Microbiology ❖ Pan Hongming, Chief Doctor, Professor, Doctoral Supervisor of Run Run Run Run Shaw Hospital Affiliated to Zhejiang University, Director of Zhejiang Provincial Health and Health Commission Tumor Targeted Therapy Technology Guidance Center ❖ Zhou Caicun, Director of Oncology Department of Shanghai Pulmonary Hospital Affiliated to Tongji University, Medicine Director of the Institute of Cancer Research ❖ Xue Yi, Senior Partner of Yida Capital ❖ Cao Shiyue, China Pharmaceutical Investment .

* More expert review lineup will be announced one after another, so stay tun.

Consult the competition, contact the organizer: 18017939885 (same as WeChat)

Multiple gifts to help resume work "continuously"

Register before May 31, you can enjoy "10% off for 3 people, 15% off for 4 people, 20% off for 5 peopl.

Before May 31st, register for BioCon Expo and BPC 2022 at the same time, and there is a 5% discount on the linkage package

Scan the code to view the official website andpre-register now

Scan the code for consultationvisit/exhibition/group/awards

Thanks to the following partners for their support

Co-organizers: Pharmaceutical Engineering Professional Committee of Zhejiang Pharmaceutical Association, Institute of Biological and Molecular Intelligence, Hangzhou International Science and Technology Innovation Center, Zhejiang University

Supporters: Shanghai Jiaotong University School of Pharmacy, Zhejiang University School of Pharmacy, SAPA-China, China Biopharmaceutical Industry Chain Innovation and Transformation Alliance, Wuhan East Lake National Independent Innovation Demonstration Zone Biomedical Industry Association, American Chinese Biomedical Association CBA, Shanghai European and American students China Biomedical Branch, National Health Industry Enterprise Management Association Precision Medicine Branch, Shanghai Pharmaceutical Association Biochemical and Biotechnology Drug Special Committee, Guangzhou Bio-Industry Alliance, National Innovative Bio-Pharma Venture Investment Service Alliance, Hangzhou Bio-Economy Digital Industrial Park, Hangzhou Times High-Tech Industrial Park

Event strategic partners: Frost & Sullivan, Flint Chain

Co-organizers of the theme forum: Binhui Biology, Bowo Biology, Aibo Biology

Cooperative media: PR Newswire, Jaffa Global Life Sciences, Yaocahui, China Bio-equipment Network, RNAScript, Sequencing China, Bio-Tong, Mystery of Life, Bio-Exploration, Bio-World, Bio-Pharmaceutical CMC, Bagua Little Monk, Peptide, Xinyaohui, GBI, Xinkangjie, Blue Rainbow, Instrument Information Network, Yaodu, Shell Club, Caijiandao, Shanshuyuan, Yaolu, Medical Valley, Arterial Network, Tumor Immune Cell Therapy Information, Biopharmaceutical Partner , Jiayu Testing Network, Yaofangzhou, Yaoy.

*Cooperative institutions are constantly being added, and the list will be continuously updated, so stay tun.

For agenda details, contact the organizerTel: 18017939885 (same as WeChat)Email: biocon@bmapglob.

com